He said: “There is controversy around Statins’ use but not none among informed parties about their effectiveness.
“When you look at the amount of data that we have – nearly 190,000 patients and more than 25,000 medical cases – that information is really quite extraordinary, in terms of its reliability.
“We know definitely Statins reduce the chance of heart attacks and strokes and we know how much they do that at different doses.
“Where there has been a good deal of discussion has been on the issue of safety of Statins.
READ MORE: Top scientist says no-deal could KILL UK innovation